Lighthouse Biotech mission is to deliver diagnostic intelligence to improve quality of life and treatment efficacy in cancer care. The product is an in vitro diagnostic device using disposable microfluidics (patented technology), enabling unique single circulating tumor cell (CTC) detection, imaging, sorting and storage. Viable, untouched CTC are biobanked as single-cells or further analysed (e.g.: sequencing). Lighthouse product boosts cancer research and drug development, eventually driving key decisions on cancer treatment.